Immedica Pharma US Inc. Announces Accepted Abstracts for Poster Presentation at the AES 2025 Annual Meeting

Chicago, IL, November 25, 2025 – Immedica Pharma US Inc. announced that two abstracts featuring ganaxolone have been accepted for poster presentation at the American Epilepsy Society (AES) 2025 Annual Meeting, taking place December 5–9 in Atlanta, Georgia. Both posters highlight important ganaxolone data and will be presented during Poster Session 3.  Details are as follows: Date: Monday, December 8 Time: 8:00 AM–2:00 PM (Authors present: 12:00–1:45 PM) Location: Georgia World Congress Center, Poster Hall B3 Poster 1: A Modified Titration Regimen of Ganaxolone in the